Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial-Reference-Cited by-同舟云学术

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

Published:2009-02-02 Issue:6 Volume:49 Page:1828-1837
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lok Anna S.,Everhart James E.,Chung Raymond T.,Kim Hae-Young,Everson Gregory T.,Hoefs John C.,Greenson Joel K.,Sterling Richard K.,Lindsay Karen L.,Lee William M.,Di Bisceglie Adrian M.,Bonkovsky Herbert L.,Ghany Marc G.,Morishima Chihiro,

Publisher

Wiley

Subject

Hepatology

Reference27 articles.

1. Hepatitis C and steatosis: a reappraisal;Lonardo;J Viral Hepat,2006

2. Steatosis in chronic hepatitis C: friend or foe?;Negro;Liver Int,2008

3. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data;Leandro;Gastroenterology,2006

4. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial;Lok;Clin Gastroenterol Hepatol,2007

5. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders;Lee;Control Clin Trials,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 90‐Day Survival Threshold: A Pivotal Determinant of Long‐Term Prognosis in HBV‐ACLF Patients – Insights from a Prospective Longitudinal Cohort Study;Advanced Science;2024-02-21

2. Non-Neoplastic Disorders of the Liver;Gastrointestinal and Liver Pathology;2024

3. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease;Biochemia medica;2022-06-15

4. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease;BIOCHEM MEDICA;2022

5. Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes;Diabetes, Obesity and Metabolism;2022-03-08